USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$250.49M
Market Cap
-
P/E Ratio
-0.45
EPS
$9.42
52 Week High
$3.96
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $44M |
Total Revenue | $48M |
Cost Of Revenue | $3.2M |
Costof Goods And Services Sold | $3.2M |
Operating Income | $2.6M |
Selling General And Administrative | $23M |
Research And Development | $307K |
Operating Expenses | $42M |
Investment Income Net | - |
Net Interest Income | -$2.5M |
Interest Income | $1.7M |
Interest Expense | $4.1M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1M |
Income Before Tax | -$71K |
Income Tax Expense | $365K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$436K |
Comprehensive Income Net Of Tax | - |
Ebit | $2.6M |
Ebitda | $3.6M |
Net Income | -$436K |
Field | Value (USD) |
---|---|
Total Assets | $45M |
Total Current Assets | $44M |
Cash And Cash Equivalents At Carrying Value | $27M |
Cash And Short Term Investments | $27M |
Inventory | $1.1M |
Current Net Receivables | $13M |
Total Non Current Assets | $822K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $3.5M |
Other Non Current Assets | - |
Total Liabilities | $51M |
Total Current Liabilities | $6.9M |
Current Accounts Payable | $2.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $366K |
Total Non Current Liabilities | $44M |
Capital Lease Obligations | $2K |
Long Term Debt | $19M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $19M |
Other Current Liabilities | $3.4M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$5.5M |
Treasury Stock | - |
Retained Earnings | -$220M |
Common Stock | $146M |
Common Stock Shares Outstanding | $27M |
Field | Value (USD) |
---|---|
Operating Cashflow | $27M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $800K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | $517K |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | -$14M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$70K |
Field | Value (USD) |
---|---|
Gross Profit | $44M |
Total Revenue | $48M |
Cost Of Revenue | $3.2M |
Costof Goods And Services Sold | $3.2M |
Operating Income | $2.6M |
Selling General And Administrative | $23M |
Research And Development | $307K |
Operating Expenses | $42M |
Investment Income Net | - |
Net Interest Income | -$2.5M |
Interest Income | $1.7M |
Interest Expense | $4.1M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1M |
Income Before Tax | -$71K |
Income Tax Expense | $365K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$436K |
Comprehensive Income Net Of Tax | - |
Ebit | $2.6M |
Ebitda | $3.6M |
Net Income | -$436K |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina.